ArticleDiscover oncology2026
A comprehensive analysis reveals the molecular mechanisms linking preservatives to prostate cancer risk.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPreservatives, widely used in food and skincare products, may influence prostate cancer (PCa) development. This study explores the effects of common preservatives, especially parabens, on PCa and their potential molecular associations via computational and database-based analyses.
methodsThis study identified potential preservative targets linked to prostate cancer through database screening (Swiss Target Prediction, STITCH, GeneCards) and extracted overlapping genes for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. A core gene network was constructed via the STRING database and Cytoscape software, and the top 20 genes by interaction strength were further analyzed using 10 machine learning algorithms to develop an optimal prognostic model. Multivariate Cox regression identified key genes as independent prognostic factors, which were preliminarily evaluated via molecular docking for preservative binding affinity. Tissue expression differences of these genes were also confirmed using the Human Protein Atlas (HPA).
resultsThis study identified 135 preservative-PCa-related genes; GO enrichment analysis showed these genes were mainly involved in apoptosis regulation, oxidative stress, signal transduction, and biosynthesis processes, while KEGG enrichment analysis linked them to endocrine resistance, chemical carcinogenesis, and lipid metabolism. The results of the machine learning prediction model showed that the Ridge model achieved the best prediction performance among the combinations of 101 prediction models with a C-index score of 0.709 and was validated across four external datasets (Cambridge, Taylor, CancerMap, GEO46602). Multivariate Cox regression identified 8 key genes (AR, BCL2L1, CASP3, CDK1, HDAC6, MMP2, PIK3CA, XIAP) as independent PCa prognostic factors-with AR, CASP3, CDK1, HDAC6, MMP2 as risk factors and BCL2L1, PIK3CA, XIAP as protective factors. Molecular docking showed all 8 genes could bind spontaneously to four parabens (methylparaben, ethylparaben, propylparaben, butylparaben), and HPA data confirmed significant expression differences of these genes between normal prostate and PCa tissues.
conclusionThis study uses computational and database-based approaches to systematically explore potential associations between parabens and PCa, identifying 8 key genes that may mediate this association and providing a theoretical foundation for formulating safer preservative usage guidelines and exploring PCa prognostic markers. Importantly, the current findings are derived from in silico prediction and public database analysis, not from experimental verification involving paraben exposure controls. The study identifies potential correlations rather than verifying direct molecular mechanisms of parabens in PCa; thus, it generates valuable scientific hypotheses that require further validation via in vitro cell experiments, animal models, and human exposure cohort studies to confirm the actual molecular mechanisms linking parabens to PCa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.